相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Virus-specific antiviral treatment for controlling severe and fatal outbreaks of feline calicivirus infection
Alvin W. Smith et al.
AMERICAN JOURNAL OF VETERINARY RESEARCH (2008)
A morpholino oligomer targeting highly conserved internal ribosome entry site sequence is able to inhibit multiple species of picornavirus
Jeffrey K. Stone et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Morpholino oligomers targeting the PB1 and NP genes enhance the survival of mice infected with highly pathogenic influenza A H7N7 virus
Guelsah Gabriel et al.
JOURNAL OF GENERAL VIROLOGY (2008)
Prospects for a dengue virus vaccine
Stephen S. Whitehead et al.
NATURE REVIEWS MICROBIOLOGY (2007)
Pharmacokinetics, biodistribution, stability and toxicity of a cell-penetrating peptide-morpholino oligomer conjugate
Adams Amantana et al.
BIOCONJUGATE CHEMISTRY (2007)
In vitro resistance selection and in vivo efficacy of morpholino oligomers against West Nile virus
Tia S. Deas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Antiviral effects of antisense morpholino oligomers in murine coronavirus infection models
Renaud Burrer et al.
JOURNAL OF VIROLOGY (2007)
Distinct RNA elements confer specificity to flavivirus RNA cap methylation events
Hongping Dong et al.
JOURNAL OF VIROLOGY (2007)
A dengue fever viremia model in mice shows reduction in viral replication and suppression of the inflammatory response after treatment with antiviral drugs
Wouter Schul et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells
Derek S. Youngblood et al.
BIOCONJUGATE CHEMISTRY (2007)
Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis
Karen Clyde et al.
JOURNAL OF VIROLOGY (2006)
Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficient splicing correction in the absence of endosomolytic agents
Said Abes et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Slower rates of clearance of viral load and virus-containing immune complexes in patients with dengue hemorrhagic fever
Wei-Kung Wang et al.
CLINICAL INFECTIOUS DISEASES (2006)
Murine model for dengue virus-induced lethal disease with increased vascular permeability
Sujan Shresta et al.
JOURNAL OF VIROLOGY (2006)
Non-structural proteins of dengue 2 virus offer limited protection to interferon-deficient mice after dengue 2 virus challenge
AE Calvert et al.
JOURNAL OF GENERAL VIROLOGY (2006)
Dystrophin expression in the mdx mouse after localised and systemic administration of a morpholino antisense oligonucteotide
S Fletcher et al.
JOURNAL OF GENE MEDICINE (2006)
Identifying accessible sites in RNA: The first step in designing antisense reagents
Wei-Hua Pan et al.
CURRENT MEDICINAL CHEMISTRY (2006)
Arginine-rich peptide conjugation to morpholino oligomers: Effects on antisense activity and specificity
MH Nelson et al.
BIOCONJUGATE CHEMISTRY (2005)
Inhibition of dengue virus serotypes 1 to 4 in Vero cell cultures with morpholino oligomers
RM Kinney et al.
JOURNAL OF VIROLOGY (2005)
Inhibition of flavivirus infections by antisense oligorners specifically suppressing viral translation and RNA replication
TS Deas et al.
JOURNAL OF VIROLOGY (2005)
Antisense phosphorodiamidate morpholino oligomer length and target position effects on gene-specific inhibition in Escherichia coli
J Deere et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization
K Jessie et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Cellular uptake of antisense morpholino oligomers conjugated to arginine-rich peptides
HM Moulton et al.
BIOCONJUGATE CHEMISTRY (2004)
Antisense oligonucleotide drug design
N Schiavone et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
Dengue 2 PDK-53 virus as a chimeric carrier for tetravalent dengue vaccine development
CYH Huang et al.
JOURNAL OF VIROLOGY (2003)
Physiologically based pharmacokinetic model for terbinafine in rats and humans
M Hosseini-Yeganeh et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Essential role of cyclization sequences in Flavivirus RNA replication
AA Khromykh et al.
JOURNAL OF VIROLOGY (2001)
Attenuation markers of a candidate dengue type 2 vaccine virus, strain 16681 (PDK-53), are defined by mutations in the 5′ noncoding region and nonstructural proteins 1 and 3
S Butrapet et al.
JOURNAL OF VIROLOGY (2000)
Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity
DW Vaughn et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
分享论文
